Christer Borgfelt

No ORCID on file · 1 paper in corpus · active 2016

Study types

  • article 1
article 2016
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
·doi:10.1038/bjc.2016.247

BACKGROUND: The aim of the present study was to investigate whether changes in the tissue expression of human epididymis-specific protein 4 (HE4) could predict therapy resistance and relapse after progestin hormone therapy for medium- and l…